Stripe-like increase of rCBV beyond the visible border of glioblastomas: Site of tumor infiltration growing after neurosurgery

Journal of Neuro-Oncology

Volumn 103, Issue 3, 2011, Pages 575-584

  Blasel, Stella ^a   Franz, Kea ^a   Ackermann, Hanns ^a   Weidauer, Stefan ^b   Zanella, Friedhelm ^a   Hattingen, Elke ^a  

^a GOETHE UNIVERSITY   (Germany)

^b Sankt Katharinen Krankenhaus GmbH   (Germany)

Author keywords

Choline; De novo CE; Glioblastoma; Perfusion MRI; rCBV

Indexed keywords

CHOLINE; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; BLOOD VOLUME; BRAIN BLOOD FLOW; CANCER GROWTH; CANCER INFILTRATION; CANCER LOCALIZATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DISEASE MARKER; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMAGE DISPLAY; MALE; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROTON NUCLEAR MAGNETIC RESONANCE; RETROSPECTIVE STUDY; STRIATE SIGN;

ADULT; AGED; ASPARAGINE; BLOOD VOLUME; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; CREATINE; FEMALE; GLIOBLASTOMA; GLUTAMIC ACID; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; REPRODUCIBILITY OF RESULTS; STATISTICS, NONPARAMETRIC; TIME FACTORS; TRITIUM; YOUNG ADULT;

EID: 79959774619     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0421-4     Document Type: Article

References (37)

1. Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ (1987) Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66:865-874 (Pubitemid 17085708)
2. Silbergeld D, Madsen C, Chicoine M (1995) Isolation of human malignant glioma cells from histologically normal brain. Presented at the CNS annual meeting, San Francisco
3. Burger PC, Dubois PJ, Schold SC Jr, Smith KR Jr, Odom GL, Crafts DC, Giangaspero F (1983) Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 58:159-169 (Pubitemid 13190247)
4. Gaspar LE, Fisher BJ, Macdonald DR, LeBer DV, Halperin EC, Schold SC Jr, Cairncross JG (1992) Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment. Int J Radiat Oncol Biol Phys 24:55-57
5. Chiang IC, Kuo YT, Lu CY, Yeung KW, Lin WC, Sheu FO, Liu GC (2004) Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiology 46:619-627 (Pubitemid 39199519)
6. Sadeghi N, Salmon I, Decaestecker C, Levivier M, Metens T, Wikler D, Denolin V, Rorive S, Massager N, Baleriaux D, Goldman S (2007) Stereotactic comparison among cerebral blood volume, methionine uptake, and histopathology in brain glioma. Am J Neuroradiol 28:455-461 (Pubitemid 46481882)
7. Stadlbauer A, Moser E, Gruber S, Buslei R, Nimsky C, Fahlbusch R, Ganslandt O (2004) Improved delineation of brain tumors. An automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas. Neuroimage 23:454-461
8. Hattingen E, Raab P, Franz K, Zanella FE, Lanfermann H, Pilatus U (2008) Myo-inositol: a marker of reactive astrogliosis in glial tumors? NMR Biomed 21:233-241
9. Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672-679
10. Hattingen E, Pilatus U, Franz K, Zanella FE, Lanfermann H (2007) Evaluation of optimal echo time for 1 H-spectroscopic imaging of brain tumors at 3 Tesla. J Magn Reson Imaging 26:427-431 (Pubitemid 47257745)
11. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR (1996) High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part i: mathematical approach and statistical analysis. Magn Reson Med 36:715-725
12. Rosen BR, Belliveau JW, Vevea JM, Brady TJ (1990) Perfusion imaging with NMR contrast agents. Magn Reson Med 14:249-265 (Pubitemid 20248610)
13. Sorensen AG, Copen WA, Ostergaard L, Buonanno FS, Gonzalez RG, Rordorf G, Rosen BR, Schwamm LH, Weisskoff RM, Koroshetz WJ (1999) Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. Radiology 210:519-527 (Pubitemid 29055324)
14. Cha S, Tihan T, Crawford F, Fischbein NJ, Chang S, Bollen A, Nelson SJ, Prados M, Berger MS, Dillon WP (2005) Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. Am J Neuroradiol 26:266-273 (Pubitemid 43073303)
15. Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D (2003) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Am J Neuroradiol 24:1989-1998 (Pubitemid 37444849)
16. Wetzel SG, Cha S, Johnson G, Lee P, Law M, Kasow DL, Pierce SD, Xue X (2002) Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 224:797-803 (Pubitemid 34919816)
17. Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas 20:37-46
18. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963-1972
19. Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ (2008) Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 9:453-461 (Pubitemid 351597795)
20. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, Harsh GR, Cosgrove GR, Halpern EF, Hochberg FH et al (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191:41-51
21. Sehgal V, Delproposto Z, Haddar D, Haacke EM, Sloan AE, Zamorano LJ, Barger G, Hu J, Xu Y, Prabhakaran KP, Elangovan IR, Neelavalli J, Reichenbach JR (2006) Susceptibilityweighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging 24:41-51
22. Lupo JM, Cha S, Chang SM, Nelson SJ (2007) Analysis of metabolic indices in regions of abnormal perfusion in patients with high-grade glioma. Am J Neuroradiol 28:1455-1461 (Pubitemid 47462926)
23. Chamberlain MC, Chalmers L (2007) A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastoma. J Neurooncol 82:207-209 (Pubitemid 46431867)
24. Galanaud D, Chinot O, Nicoli F, Confort-Gouny S, Le Fur Y, Barrie-Attarian M, Ranjeva JP, Fuentes S, Viout P, Figarella- Branger D, Cozzone PJ (2003) Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. J Neurosurg 98:269-276 (Pubitemid 36151019)
25. Scherer H (1940) The forms of growth in gliomas and their practical significance. Brain 63:1-35
26. Farin A, Suzuki SO, Weiker M, Goldman JE, Bruce JN, Canoll P (2006) Transplanted glioma cells migrate and proliferate on host brain vasculature: a dynamic analysis. Glia 53:799-808
27. Bolteus AJ, Berens ME, Pilkington GJ (2001) Migration and invasion in brain neoplasms. Curr Neurol Neurosci Rep 1:225-232
28. Giese A, Bjerkvig R, Berens ME (2003) Westphal M: cost of migration: Invasion of malignant gliomas and implications for treatment. J Clin Oncol 21:1624-1636 (Pubitemid 46594118)
29. Ljubimova JY, Lakhter AJ, Loksh A, Yong WH, Riedinger MS, Miner JH, Sorokin LM, Ljubimov AV, Black KL (2001) Over-expression of alpha 4 chain-containing laminins in human glial tumors identified by gene microarray analysis. Cancer Res 61:5601-5610 (Pubitemid 32694948)
30. Aronen HJ, Perkio J (2002) Dynamic susceptibility contrast MRI of gliomas. Neuroimaging Clin N Am 12:501-523 (Pubitemid 36015488)
31. Provenzale JM, Mukundan S, Barboriak DP (2006) Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology 239:632-649 (Pubitemid 43830599)
32. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 223:11-29 (Pubitemid 34258186)
33. Lev MH, Rosen BR (1999) Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clin N Am 9:309-331 (Pubitemid 29263861)
34. Preul C, Kuhn B, Lang EW, Mehdorn HM, Heller M, Link J (2003) Differentiation of cerebral tumors using multi-section echo planar MR perfusion imaging. Eur J Radiol 48:244-251 (Pubitemid 37491061)
35. Boxerman JL, Schmainda KM, Weisskoff RM (2006) Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. Am J Neuroradiol 27:859-867 (Pubitemid 44897737)
36. Principi M, Italiani M, Guiducci A, Aprile I, Muti M, Giulianelli G, Ottaviano P (2003) Perfusion MRI in the evaluation of the relationship between tumour growth, necrosis and angiogenesis in glioblastomas and grade 1 meningiomas. Neuroradiology 45:205-211 (Pubitemid 36700844)
37. Sugahara T, Korogi Y, Kochi M, Ikushima I, Hirai T, Okuda T, Shigematsu Y, Liang L, Ge Y, Ushio Y, Takahashi M (1998) Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. Am J Roentgenol 171:1479-1486 (Pubitemid 28531609)